The role of S1PR2 has been investigated in mast cell-dependent passive systemic anaphylaxis and found that pharmacological or genetic silencing of S1PR2 reduced the antigen-induced lung perivascular edema and anaphylactic responses. This evidence concerns the gene S1PR2 and anaphylaxis.